Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study.

Messa P, Cozzolino M, Brancaccio D, Cannella G, Malberti F, Costanzo AM, di Luzio Paparatti U, Festa V, Gualberti G, Mazzaferro S; FARO Study Group.

BMC Nephrol. 2015 Feb 6;16:11. doi: 10.1186/s12882-015-0006-8.

2.

Renal replacement therapy in Ukraine: epidemiology and international comparisons.

Kolesnyk I, Noordzij M, Kolesnyk M, Kulyzky M, Jager KJ.

Clin Kidney J. 2014 Jun;7(3):330-5. doi: 10.1093/ckj/sfu037. Epub 2014 Apr 24.

3.

Is nutritional vitamin D supplementation beneficial in dialysis patients?

Damasiewicz MJ, Toussaint ND.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):544-6. doi: 10.2215/CJN.01780215. Epub 2015 Mar 13. No abstract available.

4.

Recent advances in the management of hemodialysis patients: a focus on cardiovascular disease.

Jablonski KL, Chonchol M.

F1000Prime Rep. 2014 Aug 1;6:72. doi: 10.12703/P6-72. eCollection 2014. Review.

5.
6.

Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan.

Fukuma S, Kurita N, Fukagawa M, Akizawa T, Fukuhara S.

Kidney Int Suppl (2011). 2013 Dec;3(5):436-441. Review.

7.
8.

Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?

Vo TM, Disthabanchong S.

World J Cardiol. 2014 May 26;6(5):216-26. doi: 10.4330/wjc.v6.i5.216. Review.

9.

Active vitamin D and accelerated progression of aortic stiffness in hemodialysis patients: a longitudinal observational study.

Fortier C, Mac-Way F, De Serres SA, Marquis K, Douville P, Desmeules S, Larivière R, Agharazii M.

Am J Hypertens. 2014 Nov;27(11):1346-54. doi: 10.1093/ajh/hpu057. Epub 2014 Apr 2.

10.

Vitamin D and UV exposure in chronic kidney disease.

Krause R.

Dermatoendocrinol. 2013 Jan 1;5(1):109-16. doi: 10.4161/derm.24539. Review.

11.

Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies.

Zheng Z, Shi H, Jia J, Li D, Lin S.

BMC Nephrol. 2013 Sep 25;14:199. doi: 10.1186/1471-2369-14-199. Review.

12.

Which vitamin D in CKD-MBD? The time of burning questions.

Galassi A, Bellasi A, Auricchio S, Papagni S, Cozzolino M.

Biomed Res Int. 2013;2013:864012. doi: 10.1155/2013/864012. Epub 2013 Aug 7. Review.

13.

Mineral metabolic abnormalities and mortality in dialysis patients.

Abe M, Okada K, Soma M.

Nutrients. 2013 Mar 22;5(3):1002-23. doi: 10.3390/nu5031002. Review.

14.

Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients.

Hewitt NA, O'Connor AA, O'Shaughnessy DV, Elder GJ.

Clin J Am Soc Nephrol. 2013 Jul;8(7):1143-9. doi: 10.2215/CJN.02840312. Epub 2013 Mar 14.

15.

Organizational status of dialysis facilities and patient outcome: does higher injectable medication use mediate increased mortality?

Zhang Y, Thamer M, Kshirsagar O, Cotter DJ.

Health Serv Res. 2013 Jun;48(3):949-71. doi: 10.1111/1475-6773.12019. Epub 2012 Dec 6.

16.

Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysis.

Miller JE, Molnar MZ, Kovesdy CP, Zaritsky JJ, Streja E, Salusky I, Arah OA, Kalantar-Zadeh K.

Pharmacoepidemiol Drug Saf. 2012 Nov;21(11):1232-9. doi: 10.1002/pds.3349. Epub 2012 Sep 20.

17.
18.

Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.

Robinson BM, Tong L, Zhang J, Wolfe RA, Goodkin DA, Greenwood RN, Kerr PG, Morgenstern H, Li Y, Pisoni RL, Saran R, Tentori F, Akizawa T, Fukuhara S, Port FK.

Kidney Int. 2012 Sep;82(5):570-80. doi: 10.1038/ki.2012.136. Epub 2012 Jun 20.

19.

Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease.

Hu P, Xuan Q, Hu B, Lu L, Wang J, Qin YH.

Int J Biol Sci. 2012;8(5):663-71. doi: 10.7150/ijbs.3886. Epub 2012 May 5. Review.

20.

A simulation study of finite-sample properties of marginal structural Cox proportional hazards models.

Westreich D, Cole SR, Schisterman EF, Platt RW.

Stat Med. 2012 Aug 30;31(19):2098-109. doi: 10.1002/sim.5317. Epub 2012 Apr 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk